This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Tianyin Pharmaceutical Co., Inc. (
F2Q12 Earnings Call
February 14, 2012 08:30 am ET
James Jiayuan Tong – Chief Financial Officer & Chief Business Development Officer
Simon Minute Ren – Director of Investor Relations
Adam Waldo – Lismore Partners LLC
Steve Unger – Lazard Capital
David Sheridan – WorldOver Capital
Good day ladies and gentlemen thank you for standing by. Welcome to the Tianyin Pharmaceutical Co., Inc., second quarter 2012 annual financial results conference call. During today’s presentation, all parties will be in a listen-only mode. Following the presentation, the conference will be opened for questions. (Operator Instructions). This conference is being recorded today Tuesday February 14, 2012.
I would now like to turn the conference over to Chief Financial Officer, James Tong. Please go ahead sir.
James Jiayuan Tong
Thank you, Kristina. Good morning, good evening ladies and gentlemen. Welcome to Tianyin Pharmaceutical fiscal year 2012 second quarter earnings conference call. I am James Jiayuan Tong, Chief Financial Officer and Chief Business Development Officer of TPI along with Simon Ren, Director of Investor Relations and the other member of the Capital Market Group.
During this conference call, we’ll be reviewing the second quarter fiscal 2012 financial highlights followed by the question-and-answer period. Before we continue please know that this call will contain forward-looking statements made under the Safe Harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995.